Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q2 2019 Results - Earnings Call Transcript

Jul. 25, 2019 5:16 PM ETBristol-Myers Squibb Company (BMY)4 Comments
SA Transcripts profile picture
SA Transcripts
135.57K Followers

Bristol-Myers Squibb Company (NYSE:BMY) Q2 2019 Results Conference Call July 25, 2019 11:00 AM ET

Company Participants

John Elicker - SVP, Public Affairs and IR

Giovanni Caforio - Chairman and CEO

Charlie Bancroft - CFO

Chris Boerner - Chief Commercial Officer

Fouad Namouni - Head, Oncology Development

Conference Call Participants

Tim Anderson - Wolfe research

Seamus Fernandez - Guggenheim

Chris Schott - JP Morgan

Navin Jacob - UBS

Terence Flynn - Goldman Sachs

Steve Scala - Cowen

Matt Phipps - William Blair

Jason Gerberry - Bank of America

Umer Raffat - Evercore

David Risinger - Morgan Stanley

Operator

Good day, and welcome to the Bristol-Myers Squibb 2019 Second Quarter Results Conference Call. Today's conference is being recorded.

At this time, I would like to turn the conference over to Mr. John Elicker, Senior Vice President, Public Affairs and Investor Relations. Please go ahead, sir.

John Elicker

Thanks, Orlando, and good morning everybody. We're here to discuss our second quarter earnings as well as the news that was press released last night. With me this morning, Giovanni and Charlie will prepared remarks. Chris Boerner, our Chief Commercial Officer will be here for Q&A, as well as Fouad Namouni, our Head of Oncology Development is here for Q&A as well.

I’ll take care of the Safe Harbor language. During the call, we'll make statements about Company's future plans and prospects that constitute forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those discussed in the Company's SEC filings. These forward-looking statements represent our estimates as of today and should not be relied upon as representing our estimates as of any future date. We specifically disclaim any obligation to update forward-looking statements, even if our estimates change.

We'll also focus

Recommended For You

Comments (4)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.